Supernus Pharmaceuticals will be taken off the Nasdaq after its merger is finished on November 2, 2026.

Nov 2, 2026, 10:54 AM ETPaperworkRead the original at SEC EDGAR

Neutral

Supernus completed its merger and its old shares will leave Nasdaq. That ends public trading in those shares, but the filing gives no information on shareholder terms or the combined company's prospects.

SUPN · Supernus Pharmaceuticals, Inc.

AI read · Neutral

The AI's read

This is a stock-listing step after the merger, not a report about sales, products, or profit. The filing does not say what shareholders receive or how the combined company will perform. It changes where the old shares trade, but does not show a gain or loss in the company's prospects.

Get alerts for SUPN

Follow Supernus Pharmaceuticals, Inc. (SUPN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SUPN

Free on the App Store and Google Play, or on the web.